Qianxue Wu

Chongqing Key Laboratory Of Molecular Oncology And Epigenetics
Chongqing, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

Fibroblast-specific ablation of MHC-I antigen presentation via the IGF2 axis cripples CD8+ T cell surveillance in lung cancer.

Fibroblast-specific ablation of MHC-I antigen presentation via the IGF2 axis cripples CD8+ T cell surveillance in lung cancer.

Journal: Science advances
Published: July 17, 2026

EGR3 as a dual tumor-immune regulator: a machine learning-driven prognostic target for cold breast cancer.

EGR3 as a dual tumor-immune regulator: a machine learning-driven prognostic target for cold breast cancer.

Journal: Frontiers in immunology
Published: May 13, 2025

SB218078 inhibits angiogenesis and epithelial-mesenchymal transition in breast cancer.

SB218078 inhibits angiogenesis and epithelial-mesenchymal transition in breast cancer.

Journal: Frontiers in pharmacology
Published: December 29, 2024

DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma.

DAMPs prognostic signature predicts tumor immunotherapy, and identifies immunosuppressive mechanism of pannexin 1 channels in pancreatic ductal adenocarcinoma.

Journal: Frontiers in immunology
Published: October 24, 2024

Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer.

Fibroblast growth factor receptor risk signature predicts patient prognosis and immunotherapy resistance in colorectal cancer.

Journal: Frontiers in immunology
Published: September 09, 2024

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Insulin-like growth factor 2 drives fibroblast-mediated tumor immunoevasion and confers resistance to immunotherapy.

Journal: The Journal of clinical investigation
Published: May 29, 2024

Conduction and validation of a novel mitotic spindle assembly related signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.

Conduction and validation of a novel mitotic spindle assembly related signature in hepatocellular carcinoma: prognostic prediction, tumor immune microenvironment and drug susceptibility.

Journal: Frontiers in genetics
Published: April 04, 2024

The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer.

The Potential Prognostic Role of Oligosaccharide-Binding Fold-Containing Protein 2A (OBFC2A) in Triple-Negative Breast Cancer.

Journal: Frontiers in oncology
Published: August 01, 2021

Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancer.

Integrated multi-omics profiling of high-grade estrogen receptor-positive, HER2-negative breast cancer.

Journal: Molecular oncology
Published: February 01, 2021

Epsin 3 potentiates the NF‑κB signaling pathway to regulate apoptosis in breast cancer.

Epsin 3 potentiates the NF‑κB signaling pathway to regulate apoptosis in breast cancer.

Journal: Molecular medicine reports
Published: January 26, 2021

Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer.

Identification of autophagy-related long non-coding RNA prognostic signature for breast cancer.

Journal: Journal of cellular and molecular medicine
Published: November 19, 2020

Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.

Long-term Survival Comparison of Repeated Breast-conserving Surgery Versus Mastectomy for Patients with DCIS with Ipsilateral Breast Tumor Recurrence: A Real-world Longitudinal Study.

Journal: Clinical breast cancer
Published: October 27, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026